http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0252940-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e0daec85fdd4a4c04e22225e70a5cd9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
filingDate 1986-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca0e4e13beb96e821c378024b1bae713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df3e93f6da5b03f76875b353a9276b90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef6b6c645711349373ee57fdda99723f
publicationDate 1988-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0252940-A1
titleOfInvention Anti-sense rna for treatment of retroviral disease states
abstract The process described allows resistance to infection caused by pathogenic retroviruses to be developed. Cells susceptible to infection by a pathogenic retrovirus are transformed with a polynucleotide directing RNA transcription which is complementary to a region of the retroviral genome and which is effective in interrupting retroviral replication by substantially preventing the formation of pathogenic virions in the treated cell and its line. The cells are preferably explanted during the therapeutic transformation step, then introduced into the treated host.
priorityDate 1985-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8605516-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8301451-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378

Total number of triples: 22.